Signs of Central Sensitization in Tension-type Headache (CSTTH)

March 27, 2024 updated by: University Ghent

Are Signs of Central Sensitization Present in Tension-type Headache?

The goal of this observational study is to assess the pain sensitivity in tension-type headache patients. The main question it aims to answer is:

- Are signs of central sensitization present in tension-type headache?

Participants will be asked to fill out baseline questionnaires and they will be assessed during 1 test moment (static and dynamic quantitative sensory testing).

Researchers will compare tension-type headache patients with healthy controls to see if signs of central sensitization are only present in the tension-type headache group.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

66

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • East-Flanders
      • Ghent, East-Flanders, Belgium, 9000
        • Recruiting
        • Ghent University
        • Contact:
          • Jessica Van Oosterwijck, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

This study will involve participation from various populations, specifically patients with episodic tension headache, patients with chronic tension headache, and healthy pain-free controls.

Description

Inclusion Criteria:

  1. Diagnosis of tension headache according to globally recognized criteria (ICHD-3) or verified by a physician
  2. Diagnosis of tension headache confirmed by a questionnaire (Headache Screening Questionnaire)
  3. Not pregnant or given birth in the past year since a change in hormone levels can affect pain experience
  4. Adults between the ages of 18 and 65
  5. Proficient in the Dutch language

Exclusion Criteria:

  1. Other diagnosis of headache or a mixed form
  2. Other existing condition involving central nervous system sensitivity
  3. Other structural neurological syndromes
  4. Any condition involving the brain in the past
  5. Procedure on the head, neck, or shoulder in the past 3 years
  6. Currently suffering from a psychiatric condition
  7. Athletes competing at a competitive level
  8. Not proficient in the Dutch language
  9. Currently pregnant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Episodic tension-type headache
Patients with 1 - 14 days of TTH/month.
Assessment of the heat and cold pain thresholds, temporal summation, conditioned pain modulation, pressure pain thresholds, electrical pain thresholds, and withdrawal reflex.
Chronic tension-type headache
Patients with more than 14 days TTH/month
Assessment of the heat and cold pain thresholds, temporal summation, conditioned pain modulation, pressure pain thresholds, electrical pain thresholds, and withdrawal reflex.
Healthy controls
Participants without tension-type headache
Assessment of the heat and cold pain thresholds, temporal summation, conditioned pain modulation, pressure pain thresholds, electrical pain thresholds, and withdrawal reflex.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain sensitivity for heat stimuli
Time Frame: Baseline
Hypersensitivity for heat pain. The heat stimulus will be delivered with the TSA-2, using a thermode.
Baseline
Pain sensitivity for cold stimuli
Time Frame: Baseline
Hypersensitivity for cold pain. the cold stimulus will be delivered with the TSA-2, using a thermode.
Baseline
Pain sensitivity for electrical stimuli
Time Frame: Baseline
Hypersensitivity for electrical pain. The electrical stimulus will be given with the Digitimer, using an electrode.
Baseline
Pain sensitivity for pressure
Time Frame: Baseline
Hypersensitivity for pressure pain. Pressure will be delivered using a digital algometer.
Baseline
Function of the pain facilitating pathways
Time Frame: Baseline
Temporal summation will be measured. This gives an idea of the (dys)function of the endogenous pain facilitation system.
Baseline
Function of the pain inhibiting pathways
Time Frame: Baseline
Conditioned pain modulation will be measured. This gives an idea of the (dys)function of the endogenous pain inhibiting system. A noxious conditioning heat stimulus will be given at the tibial anterior muscle. A test heat or pressure stimulus will be given at the temporalis muscle. The pain-inhibits-pain paradigm will be tested.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jessica Van Oosterwijck, Prof, Revalidatiewetenschappen en kinesitherapie

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

February 14, 2024

First Submitted That Met QC Criteria

March 14, 2024

First Posted (Actual)

March 21, 2024

Study Record Updates

Last Update Posted (Actual)

April 1, 2024

Last Update Submitted That Met QC Criteria

March 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tension-Type Headache

Clinical Trials on Quantitative Sensory Testing

Subscribe